Bidirectional Modulation of the Voltage-Gated Sodium (Nav1.6) Channel by Rationally Designed Peptidomimetics.


Journal

Molecules (Basel, Switzerland)
ISSN: 1420-3049
Titre abrégé: Molecules
Pays: Switzerland
ID NLM: 100964009

Informations de publication

Date de publication:
24 Jul 2020
Historique:
received: 21 06 2020
revised: 14 07 2020
accepted: 22 07 2020
entrez: 30 7 2020
pubmed: 30 7 2020
medline: 2 3 2021
Statut: epublish

Résumé

Disruption of protein:protein interactions (PPIs) that regulate the function of voltage-gated Na

Identifiants

pubmed: 32722255
pii: molecules25153365
doi: 10.3390/molecules25153365
pmc: PMC7435778
pii:
doi:

Substances chimiques

NAV1.6 Voltage-Gated Sodium Channel 0
Peptidomimetics 0
SCN8A protein, human 0
fibroblast growth factor 14 0
Fibroblast Growth Factors 62031-54-3

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIH HHS
ID : R01MH124351
Pays : United States
Organisme : NIGMS NIH HHS
ID : T32 GM008280
Pays : United States
Organisme : NIA NIH HHS
ID : T32AG051131
Pays : United States
Organisme : NIH HHS
ID : R01MH095995
Pays : United States
Organisme : NIDA NIH HHS
ID : U18 DA052504
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH124351
Pays : United States
Organisme : NIH HHS
ID : S10OD023576
Pays : United States
Organisme : NIH HHS
ID : S10 OD023576
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH111107
Pays : United States
Organisme : NIH HHS
ID : P30DA028821
Pays : United States
Organisme : NIH HHS
ID : R01MH111107
Pays : United States

Références

J Biol Chem. 2016 May 20;291(21):11268-84
pubmed: 26994141
Assay Drug Dev Technol. 2012 Apr;10(2):148-60
pubmed: 22364545
Annu Rev Neurosci. 2011;34:441-66
pubmed: 21469956
J Physiol. 2005 Nov 15;569(Pt 1):179-93
pubmed: 16166153
Lancet. 2005 Jul 30-Aug 5;366(9483):371-7
pubmed: 16054936
Sci Rep. 2019 Nov 15;9(1):16890
pubmed: 31729429
Biophys J. 1978 May;22(2):283-94
pubmed: 656545
Front Cell Neurosci. 2016 Jun 13;10:156
pubmed: 27378853
Biol Psychiatry. 2003 Dec 1;54(11):1241-8
pubmed: 14643092
J Med Chem. 2019 Nov 14;62(21):9618-9641
pubmed: 31525968
Physiol Behav. 2012 Feb 1;105(3):661-8
pubmed: 22001493
J Med Chem. 2000 May 18;43(10):1986-92
pubmed: 10821711
Mol Psychiatry. 2003 Feb;8(2):186-94
pubmed: 12610651
Mol Autism. 2020 Apr 7;11(1):23
pubmed: 32264956
Nat Neurosci. 2014 Aug;17(8):1022-30
pubmed: 25065439
Transl Psychiatry. 2013 Jun 04;3:e266
pubmed: 23736119
Neuroscience. 1999;93(4):1349-58
pubmed: 10501459
Biochim Biophys Acta. 2014 Jan;1838(1 Pt A):43-55
pubmed: 23665295
Annu Rev Physiol. 2001;63:871-94
pubmed: 11181979
CNS Drugs. 2007;21(1):47-71
pubmed: 17190529
J Neurosci. 2007 Oct 31;27(44):12033-44
pubmed: 17978045
Trends Neurosci. 2018 Jul;41(7):442-456
pubmed: 29691040
Neuropsychopharmacology. 1998 Sep;19(3):206-19
pubmed: 9653709
Bioorg Med Chem Lett. 2019 Feb 1;29(3):413-419
pubmed: 30587448
Am J Hum Genet. 2001 Jun;68(6):1327-32
pubmed: 11359211
Cell Rep. 2018 Apr 10;23(2):555-567
pubmed: 29642012
Biol Psychiatry. 2015 Feb 1;77(3):212-222
pubmed: 25173629
J Psychopharmacol. 2001 Dec;15(4):297-301
pubmed: 11769825
Proc Natl Acad Sci U S A. 2005 Dec 13;102(50):18177-82
pubmed: 16326807
Sci Rep. 2018 Mar 14;8(1):4483
pubmed: 29540853
Nat Neurosci. 2009 Feb;12(2):200-9
pubmed: 19151710
Structure. 2012 Jul 3;20(7):1167-76
pubmed: 22705208
Arch Gen Psychiatry. 1999 Oct;56(10):950
pubmed: 10530638
Proc Natl Acad Sci U S A. 2019 May 28;116(22):10763-10772
pubmed: 31072926
J Clin Psychopharmacol. 2007 Jun;27(3):263-72
pubmed: 17502773
Brain Res Brain Res Rev. 1999 Dec;31(1):6-41
pubmed: 10611493
ACS Chem Neurosci. 2018 May 16;9(5):976-987
pubmed: 29359916
Neuroscientist. 2007 Apr;13(2):148-59
pubmed: 17404375
Brain Res. 1989 May 22;487(2):267-77
pubmed: 2525062
PLoS One. 2015 Feb 06;10(2):e0117246
pubmed: 25659151
Angew Chem Int Ed Engl. 2015 Jul 27;54(31):8896-927
pubmed: 26119925
Nature. 2012 Jul 11;487(7406):183-9
pubmed: 22785313
Arch Neurol. 2009 Jan;66(1):21-6
pubmed: 19139296
Nat Genet. 2000 Apr;24(4):343-5
pubmed: 10742094
Proc Natl Acad Sci U S A. 2008 Jul 15;105(28):9799-804
pubmed: 18621678
CNS Neurol Disord Drug Targets. 2014;13(9):1559-70
pubmed: 25426956
J Neurosci Res. 1997 Sep 1;49(5):515-21
pubmed: 9302072
Curr Opin Drug Discov Devel. 2009 Jan;12(1):31-9
pubmed: 19152211

Auteurs

Nolan M Dvorak (NM)

Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, TX 75901, USA.

Paul A Wadsworth (PA)

Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, TX 75901, USA.

Pingyuan Wang (P)

Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, TX 75901, USA.

Haiying Chen (H)

Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, TX 75901, USA.

Jia Zhou (J)

Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, TX 75901, USA.
Center for Addiction Research, University of Texas Medical Branch, Galveston, TX 75901, USA.

Fernanda Laezza (F)

Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, TX 75901, USA.
Center for Addiction Research, University of Texas Medical Branch, Galveston, TX 75901, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH